€2.45
0.41%
Xetra, Wed, Dec 04 2024
ISIN
DE000A11QVV0
Symbol
WL6
Index
Sector
Industry

Heidelberg Pharma Stock price

€2.45
-0.07 2.78% 1M
-0.45 15.52% 6M
-1.29 34.49% YTD
-0.63 20.45% 1Y
-2.63 51.77% 3Y
+0.28 12.90% 5Y
+0.45 22.50% 10Y
Xetra, Closing price Wed, Dec 04 2024
+0.01 0.41%
ISIN
DE000A11QVV0
Symbol
WL6
Index
Sector
Industry

Key metrics

Market capitalization €114.17m
Enterprise Value €98.94m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 11.68
P/S ratio (TTM) P/S ratio 13.48
P/B ratio (TTM) P/B ratio 3.19
Revenue growth (TTM) Revenue growth -10.39%
Revenue (TTM) Revenue €8.47m
EBIT (operating result TTM) EBIT €-21.20m
Free Cash Flow (TTM) Free Cash Flow €-30.25m
Cash position €36.57m
EPS (TTM) EPS €-0.40
P/E forward negative
P/S forward 10.62
EV/Sales forward 9.20
Show more

Is Heidelberg Pharma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,878 stocks worldwide.

Heidelberg Pharma Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Heidelberg Pharma forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Heidelberg Pharma forecast:

Buy
100%

Financial data from Heidelberg Pharma

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
8.47 8.47
10% 10%
100%
- Direct Costs 2.53 2.53
-
30%
5.94 5.94
-
70%
- Selling and Administrative Expenses 4.61 4.61
75% 75%
54%
- Research and Development Expense 22 22
30% 30%
256%
-20 -20
27% 27%
-240%
- Depreciation and Amortization 0.87 0.87
4% 4%
10%
EBIT (Operating Income) EBIT -21 -21
26% 26%
-250%
Net Profit -19 -19
16% 16%
-222%

In millions EUR.

Don't miss a Thing! We will send you all news about Heidelberg Pharma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Heidelberg Pharma Stock News

EQS
29 days ago
Dieser Text enthält bestimmte zukunftsgerichtete Aussagen, die sich auf den Geschäftsbereich der Gesellschaft beziehen und die sich durch den Gebrauch von zukunftsgerichteter Terminologie wie etwa “schätzt”, “glaubt”, “erwartet”, “könnte”, “wird”, “sollte”, “zukünftig”, “möglich” oder ähnliche Au...
EQS
about one month ago
Dieser Text enthält bestimmte zukunftsgerichtete Aussagen, die sich auf den Geschäftsbereich der Gesellschaft beziehen und die sich durch den Gebrauch von zukunftsgerichteter Terminologie wie etwa “schätzt”, “glaubt”, “erwartet”, “könnte”, “wird”, “sollte”, “zukünftig”, “möglich” oder ähnliche Au...
More Heidelberg Pharma News

Company Profile

Heidelberg Pharma AG is a holding company, which engages in the development of diagnostic and therapeutic oncology products for the detection and targeted treatment of various types of cancer. It operates through the following segments: Customer Specific Research, Diagnostics, and Therapeutics. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Ladenburg, Germany.

Head office Germany
CEO Andreas Pahl
Employees 105
Founded 1997
Website heidelberg-pharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today